Cargando…
Mesenchymal Stem Cells (MSCs) as a Potential Therapeutic Strategy in COVID-19 Patients: Literature Research
In 2019, an outbreak of an unknown coronavirus – SARS-CoV-2 – responsible for COVID-19 disease, was first reported in China, and evolved into a pandemic of huge dimensions and raised serious concerns for global health. The number of critical cases continues to increase dramatically, while vaccines a...
Autores principales: | Coelho, André, Alvites, Rui Damásio, Branquinho, Mariana Vieira, Guerreiro, Susana G., Maurício, Ana Colette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710935/ https://www.ncbi.nlm.nih.gov/pubmed/33330498 http://dx.doi.org/10.3389/fcell.2020.602647 |
Ejemplares similares
-
The Application of MSCs-Derived Extracellular Vesicles in Bone Disorders: Novel Cell-Free Therapeutic Strategy
por: Liu, Shuyu, et al.
Publicado: (2020) -
MSCs vs. iPSCs: Potential in therapeutic applications
por: Thanaskody, Kalaiselvaan, et al.
Publicado: (2022) -
Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs)
por: Pacini, Simone
Publicado: (2014) -
Mesenchymal Stem/Stromal Cells and Their Paracrine Activity—Immunomodulation Mechanisms and How to Influence the Therapeutic Potential
por: Alvites, Rui, et al.
Publicado: (2022) -
Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration
por: Bouland, Cyril, et al.
Publicado: (2021)